Phosphatidylserine inhibits inflammatory responses in interleukin-1β-stimulated fibroblast-like synoviocytes and alleviates carrageenan-induced arthritis in rat

Nutrition Research

Volumn 33, Issue 3, 2013, Pages 242-250

  Yeom, Mijung ^a   Hahm, Dae Hyun ^a   Sur, Bong Jun ^a   Han, Jeong Jun ^b   Lee, Hye Jung ^a   Yang, Hyung In ^c   Kim, Kyoung Soo ^c  

^a Kyung Hee University   (South Korea)

^b Glonet BU   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

Author keywords

Arthritis; Carrageenan; Fibroblast like synoviocyte; Inflammation; Pain; Phosphatidylserine (PS); Rat

Indexed keywords

AUTACOID; CARRAGEENAN; CELECOXIB; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEAR FACTOR KAPPA B ALPHA; PHOSPHATIDYLSERINE; PREDNISOLONE; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANALGESIC ACTIVITY; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARTHRITIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG DOSE COMPARISON; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST LIKE SYNOVIOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; PAW PRESSURE TEST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SOYBEAN; SYNOVIOCYTE; TREATMENT DURATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CARRAGEENAN; ENZYME ACTIVATION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHATIDYLSERINES; PROSTAGLANDINS E; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; GLYCINE MAX; RATTUS;

EID: 84875375372     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2013.01.006     Document Type: Article

References (29)

1. Gay S., Gay R.E., Koopman W.J. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?. Ann Rheum Dis 1993, 52(Suppl 1):S39-S47.
2. Lee Y.A., Kim J.Y., Hong S.J., Lee S.H., Yoo M.C., Kim K.S., et al. Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients. Clin Rheumatol 2007, 26:2023-2029.
3. Mor A., Abramson S.B., Pillinger M.H. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 2005, 115:118-128.
4. Alonzi T., Fattori E., Lazzaro D., Costa P., Probert L., Kollias G., et al. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998, 187:461-468.
5. Joosten L.A., Lubberts E., Helsen M.M., Saxne T., Coenen-de Roo C.J., Heinegard D., et al. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res 1999, 1:81-91.
6. Szekanecz Z., Besenyei T., Paragh G., Koch A.E. New insights in synovial angiogenesis. Joint Bone Spine 2010, 77:13-19.
7. Firestein G.S., Manning A.M. Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum 1999, 42:609-621.
8. Kiriakidis S., Andreakos E., Monaco C., Foxwell B., Feldmann M., Paleolog E. VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2. J Cell Sci 2003, 116:665-674.
9. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001, 107:7-11.
10. Vance J.E., Steenbergen R. Metabolism and functions of phosphatidylserine. Prog Lipid Res 2005, 44:207-234.
11. Richter Y., Herzog Y., Cohen T., Steinhart Y. The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study. Clin Interv Aging 2010, 5:313-316.
12. Krahling S., Callahan M.K., Williamson P., Schlegel R.A. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ 1999, 6:183-189.
13. Otsuka M., Tsuchiya S., Aramaki Y. Involvement of ERK, a MAP kinase, in the production of TGF-beta by macrophages treated with liposomes composed of phosphatidylserine. Biochem Biophys Res Commun 2004, 324:1400-1405.
14. Kim K.S., Park E.K., Ju S.M., Jung H.S., Bang J.S., Kim C., et al. Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes. Arthritis Res Ther 2007, 9:R80.
15. Bang J.S., Oh da H., Choi H.M., Sur B.J., Lim S.J., Kim J.Y., et al. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther 2009, 11:R49.
16. Youn J.I., Collazo M., Shalova I.N., Biswas S.K., Gabrilovich D.I. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol 2012, 91:167-181.
17. Zhang B., Wang X., Cai F., Chen W., Loesch U., Bitzer J., et al. Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK. Tumour Biology 2012.
18. Schmitz M.L., Mattioli I., Buss H., Kracht M. NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 2004, 5:1348-1358.
19. 2, and PAF. J Clin Invest 1998, 101:890-898.
20. Ramos G.C., Fernandes D., Charao C.T., Souza D.G., Teixeira M.M., Assreuy J. Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo. Br J Pharmacol 2007, 151:844-850.
21. Kay J., Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2004, 43(Suppl 3):iii2-iii9.
22. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995, 75:125-131.
23. Paleolog E.M. Angiogenesis in rheumatoid arthritis. Arthritis Res 2002, 4(Suppl 3):S81-S90.
24. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543.
25. Pepeu G., Pepeu I.M., Amaducci L. A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain?. Pharmacol Res 1996, 33:73-80.
26. Bruni A., Orlando P., Mietto L., Viola G. Phospholipid metabolism in rat intestinal mucosa after oral administration of lysophospholipids. Adv Exp Med Biol 1992, 318:243-249.
27. Nishijima M., Kuge O., Akamatsu Y. Phosphatidylserine biosynthesis in cultured Chinese hamster ovary cells. I. Inhibition of de novo phosphatidylserine biosynthesis by exogenous phosphatidylserine and its efficient incorporation. J Biol Chem 1986, 261:5784-5789.
28. Morton S., Davis R.J., McLaren A., Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 2003, 22:3876-3886.
29. Sweeney S.E., Hammaker D., Boyle D.L., Firestein G.S. Regulation of c-Jun phosphorylation by the I kappa B kinase-epsilon complex in fibroblast-like synoviocytes. J Immunol 2005, 174:6424-6430.